IP Library Assignment 068089/0649
Patent Assignment
Reel/Frame 068089/0649

Assignment of Assignor's Interest

Recorded: 2024-07-26 Pages: 10
Assignors
LI, SHUANG
Executed: 2024-07-19
ZHOU, YANJING
Executed: 2024-07-19
GU, YUYAO
Executed: 2024-07-19
ZHENG, BO
Executed: 2024-07-19
GAO, MING
Executed: 2024-07-19
HE, HONGYAN
Executed: 2024-07-19
DING, JUNLU
Executed: 2024-07-19
YOU, MEI
Executed: 2024-07-19
Assignee
SHANGHAI SYNTHEALL PHARNMACEUTICALS
5TH FLOOR, BUILDING 5, 90 DELIN ROAD, PUDONG NEW DISTRICT, SHANGHAI, SHANGHAI, 200131, CHINA
Covered Properties (3)
Crystalline Forms of N-[4-[4-(4-Morpholinyl)-7H-Pyrrolo[2,3-D]Pyrimidin-6-Yl]Phenyl]-4-[[3(R)-[(1-Oxo-2-Propen-1-Yl)Amino]-1-Piperidinyl]Methyl]-2-Pyridinecarboxamide as a Covalent Inhibitor of Menin-Mll Interaction
Crystalline Forms of N-[4-[4-(4-Morpholinyl)-7H-Pyrrolo[2,3-D]Pyrimidin-6-Yl]Phenyl]-4-[[3(R)-[(1-Oxo-2-Propen-1-Yl)Amino]-1-Piperidinyl]Methyl]-2-Pyridinecarboxamide as a Covalent Inhibitor of Menin-Mll Interaction
CRYSTALLINE FORMS OF N-[4-[4-(4-MORPHOLINYL)-7H-PYRROLO[2,3-d]PYRIMIDIN-6-YL]PHENYL]-4-[[3(R)-[(1-OXO-2-PROPEN-1-YL)AMINO]-1-PIPERIDINYL]METHYL]-2-PYRIDINECARBOXAMIDE
Application: 18/427,226 →
Publication: US 2024/0300950
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 26, 2024
From: PUPPALI, SATISH GOUD; WONG, ANGELINA SAU MAN; QIU, YIHONG; KIRSCHBERG, THORSTEN A.
To: BIOMEA FUSION, INC.
Reel/Frame 068089/0636 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 068089 Frame: 0649. Assignor(S) Hereby Confirms the Assignment . Jul 31, 2024
From: LI, SHUANG; ZHOU, YANJING; GU, YUYAO; ZHENG, BO
To: SHANGHAI SYNTHEALL PHARMACEUTICALS
Reel/Frame 068202/0888 →
Assignment of Assignor's Interest Jul 31, 2024
From: SHANGHAI SYNTHEALL PHARMACEUTICALS
To: BIOMEA FUSION, INC.
Reel/Frame 068234/0416 →